Crystalline form refers to the specific solid-state arrangement of molecules in an Active Pharmaceutical Ingredient (API), crucial for drug stability, solubility, and bioavailability.
In pharmaceutical manufacturing, the crystalline form of an API is a critical quality attribute defined by its molecular arrangement in a three-dimensional lattice structure. This polymorphic form determines physical-chemical properties including melting point, dissolution rate, hygroscopicity, and mechanical strength. Pharmaceutical-grade APIs require controlled crystallization processes to ensure batch-to-batch consistency, regulatory compliance, and therapeutic efficacy. The crystalline form must be maintained throughout manufacturing, packaging, and storage to prevent phase transitions that could compromise drug performance.
诱因 → 失效模式 → 工程缓解
不是客户评论，也不是实时热度。以下维度用于前期 RFQ 准备和供应商评估。
这些分值是采购评估维度示例，不代表真实客户评分、具体国家买家反馈或实时询盘。
Crystalline form affects dissolution rate, bioavailability, stability, and manufacturability. Different polymorphs can have significantly different therapeutic properties, making form control essential for drug safety and efficacy.
Through controlled crystallization parameters (temperature, cooling rate, agitation, seeding), proper solvent selection, and environmental controls (humidity, temperature) during downstream processing and storage to prevent polymorphic transitions.
X-ray Powder Diffraction (XRPD), Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), Fourier Transform Infrared Spectroscopy (FTIR), and Raman spectroscopy are commonly used for polymorph identification and quantification.
CNFX 是开放目录，不是交易平台或采购代理。工厂资料和表单用于帮助你准备直接沟通。
CNFX 制造商资料、技术分类、公开产品信息和持续合理性检查。
说明目标数量、应用场景、交期和关键技术要求，用于准备 RFQ 或供应商评估。